Less radiation for breast cancer? a trial tests a smarter, response-based approach

NCT ID NCT07724769

Not yet recruiting Disease control Sponsor: Aya Ahmed Sayed Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial is investigating whether women with node-positive breast cancer whose lymph nodes are cancer-free after chemotherapy can safely receive less extensive radiation. Instead of radiating the entire lymph node region, the study compares standard radiation to a more targeted approach. The goal is to maintain a low risk of cancer recurrence while reducing side effects from treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: adjuvant radiotherapy (radiation therapy to the breast or chest wall, with or without regional lymph nodes)
What this could lead to: If successful, this approach could allow many breast cancer patients to avoid unnecessary radiation to the lymph nodes, reducing side effects without increasing the risk of cancer returning.
What could go wrong: This is a relatively small, early-stage study. It is not yet known whether reducing radiation will lead to higher recurrence rates in the long term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.